Healthtech Startups
17,200 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
0 investors
Neuro-Kinesis develops biosensor-integrated surgical instruments that deliver real-time biological feedback to surgeons during procedures. The company focuses on catheter-based imaging tools and neurosurgical retractors designed to improve procedural outcomes in cardiac mapping, organ visualization, and brain surgery.
0 investors
0 investors
0 investors
NeuroCytonix operates a clinical research center in Monterrey, Mexico that develops and conducts investigational protocols for neurological conditions including cerebral palsy, autism, stroke, and traumatic brain injury. The center is designed to provide personalized clinical care and research in compliance with international good clinical practice standards.
0 investors
NeuroEM Therapeutics develops MemorEM, a wearable head device that administers transcranial electromagnetic treatment to treat cognitive decline and Alzheimer's disease. The device targets patients with neurodegenerative diseases through a non-invasive, in-home treatment delivered by healthcare professionals.
0 investors
0 investors
0 investors
0 investors
Neurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness. The system pairs a non-invasive EEG headset, a thought-controlled wireless handpiece, and a tablet to guide and track therapy.
0 investors
NeuroNascent develops therapeutics aimed at generating new neurons and regenerating existing ones to treat neurological disorders. Its R&D pipeline targets conditions including Alzheimer's disease, Parkinson's disease, and developmental delay, alongside a veterinary medicine program.
0 investors
0 investors
NMTC develops neurotechnology combining medical devices and artificial intelligence, supported by scientific and AI advisory boards. The company works with medical and neuroscience experts to advance its innovations.
0 investors
NeuroPro is developing NPT 2042, a drug candidate targeting epilepsy, with reported efficacy in pharmacology models comparable to NKCC antagonists such as bumetanide and furosemide. The compound has shown plasma exposure across species including humans and no negative safety signals in animals or humans to date.
0 investors
0 investors
0 investors
0 investors
Neurotone develops auditory training software for hearing loss patients. The platform helps patients improve hearing comprehension through brain-based learning, built on over 20 years of clinical research in hearing care.
0 investors
0 investors
NeuTigers develops edge-AI decision support software that remotely detects and monitors early symptoms of chronic and rare diseases, aiming to enable proactive intervention for healthcare providers. Founded in 2018, the company applies deep learning and IoT-based techniques to process real-time data at the source for healthcare and industrial applications.
0 investors
0 investors
0 investors